1. All Products
  2. LABETALOL hydrochloride, 200mg, tab.
Liste de prix publique

LABETALOL hydrochloride, 200mg, tab.

https://medicalguidelines.msf.org/en/node/426
https://unicat.msf.org/cat/product/12109
STD DORALABE2T-

Valid Article

Former Code(s): -X
12.3 - Antihypertensive medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C07AG01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://unicat.msf.org/web/image/product.template/572516/image_1920?unique=87e498c

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

LABETALOL

Therapeutic Action

Non cardioselective beta-blocker

Indications

Gestational and chronic hypertension in pregnant women

Instructions for use

Both strengths, 100 mg (DORALABE1T-) and 200 mg (DORALABE2T-), must be ordered to enable initiation and dose adjustment, as +the 200 mg tablet is not breakable.

Labetalol is considered as the first-line treatment for hypertension in pregnancy, with Nifedipine as the second alternative and methyldopa as the third due to more side effects and lower effectiveness.

Precautions for Use

After birth, monitor the neonate closely for bradycardia and hypoglycaemia.

Contraindicated in uncontrolled asthma and in heart failure.

Storage

Below 25°C ‐ Protect from sunlight ‐ Protect from humidity